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Abstract
Background: Schistosomiasis remains a global public health challenge, with 93% of the,237 million infections occurring in
sub-Saharan Africa. Though rarely fatal, its recurring nature makes it a lifetime disorder with significant chronic health
burdens. Much of its negative health impact is due to non-specific conditions such as anemia, undernutrition, pain, exercise
intolerance, poor school performance, and decreased work capacity. This makes it difficult to estimate the disease burden
specific to schistosomiasis using the standard DALY metric.
Methodology/Principal Findings: In our study, we used Pediatric Quality of Life Inventory (PedsQL), a modular instrument
available for ages 2–18 years, to assess health-related quality of life (HrQoL) among children living in a Schistosoma
haematobium-endemic area in coastal Kenya. The PedsQL questionnaires were administered by interview to children aged
5–18 years (and their parents) in five villages spread across three districts. HrQoL (total score) was significantly lower in
villages with high prevalence of S. haematobium (24.0%, p,0.001) and among the lower socioeconomic quartiles (22.0%,
p,0.05). A greater effect was seen in the psychosocial scales as compared to the physical function scale. In moderate
prevalence villages, detection of any parasite eggs in the urine was associated with a significant 2.1% (p,0.05) reduction in
total score. The PedsQL reliabilities were generally high (Cronbach alphas $0.70), floor effects were acceptable, and
identification of children from low socioeconomic standing was valid.
Conclusions/Significance: We conclude that exposure to urogenital schistosomiasis is associated with a 2–4% reduction in
HrQoL. Further research is warranted to determine the reproducibility and responsiveness properties of QoL testing in
relation to schistosomiasis. We anticipate that a case definition based on more sensitive parasitological diagnosis among
younger children will better define the immediate and long-term HrQoL impact of Schistosoma infection.
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Introduction
Schistosomiasis remains a public challenge globally with 93% of
the estimated 237 million infections occurring in Africa [1]. Its
transmission is mainly influenced by exposures to environmental
factors (contact with infested water, distance to infected water
bodies), individual characteristics (treatment history, sex, and age)
and socioeconomic factors (occupation and education) [2–5].
Schistosomiasis is rarely fatal but due to its recurring nature is
manifested as a persistent chronic disorder in endemic areas,
resulting in significant health burden [6–8]. It is estimated that
people living in Schistosoma -endemic areas carry the infection one-
third to one-half of their lives [9], yet they may only rarely exhibit
the advanced morbidities that are classically associated with
schistosomiasis, such as advanced hepatic fibrosis with portal
hypertension (for S. mansoni), or bladder and kidney deformity,
bladder cancer, or infertility (for S. haematobium) [7]. In reality,
much of the negative health impact is due to less obvious or
specific conditions such as anemia, undernutrition, abdominal
pain, exercise intolerance, poor school performance, and lowered
work capacity [7,8,10]. The non-specificity of chronic infection
symptoms, manifested as these subtle morbidities, makes it difficult
to accurately estimate the specific disease burden due to
schistosomiasis. As pointed out by King and Bertino [11], the
present disability-adjusted life year (DALY) system of the World
Bank and the World Health Organization (WHO) [12] not only
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ignores these morbidities, but also disregards the pervasiveness of
co-morbidities, including polyparasitism, in Schistosoma-endemic
areas.
While the debate on DALY estimates of disease burden persists,
attention is turning to the use of patient-reported outcomes, such
as health-related quality of life (HrQoL) [6,7,11,13]. Use of quality
of life (QoL) assessment tools in evaluating schistosomiasis and
other neglected tropical disease (NTD) burden is gaining greater
standing [13–16]. Quality of Life is defined as an individual’s
perception of one’s position in life in the context of culture and
value systems, as well as in relation to one’s goals, expectations,
standards and concerns [17]. The World Health Organization
defines health as being ‘‘not only the absence of disease and
infirmity but also the presence of physical, mental, and social well-
being’’ [18]. HrQoL therefore refers to the physical, psychological,
and social scales of health seen in functional areas influenced by a
person’s experiences, beliefs, expectations, and perceptions.
Measuring HrQoL is an important outcomes indicator in
evaluating health-care interventions and treatments, in under-
standing the burden of disease, in identifying health inequalities, in
allocating health resources, and in epidemiological studies and
health surveys [19]. Unlike in other chronic conditions such
cancer and sickle cell disease where HrQoL tools have been widely
used, for NTDs these tools have only been used to assess the
burden of advanced schistosomiasis (using EQ-5D plus or WHO
QoL-bref questionnaires) [13,15,20], soil-transmitted helminthes
(using both EQ-5D and SF-12) [16], and echinococcosis (using SF-
12) [21], and to assess the burden of polyparasitism in Cote
d’Ivoire (using SF-36v2 questionnaire but only the physical scale)
[14]. SF-12 has also been used to describe the impact of acute
schistosomiasis on quality of life in a group of travelers returning
from a luxury safari trip in Tanzania [22]. Results of most of these
studies suggest that the burden of schistosomiasis has been
consistently underestimated [13,15,21]. Moreover, in two of these
studies by Jia and colleagues, by only targeting people with chronic
schistosomiasis [13] or advanced schistosomiasis [15] it was not
possible to contrast HrQoL findings among schistosomiasis
patients to people living in same localities without schistosomiasis.
Additionally all these studies used QoL tools that do not capture
the changes in QoL that occur in different developmental stages of
children, the most important epidemiological demographic for
active Schistosoma infection [23].
The choice of the HrQoL tool depends mainly on the purpose
(the health conditions being investigated) and the target population
(the general population, adults only or children only) [24,25].
Measurement of HrQoL in children is particularly difficult
because of the need for different instruments in different age
groups, and the need for instruments that accommodate the
different cultures. Two types of HrQoL measures have been
developed, generic and condition-specific instruments. Generic or non-
categorical instruments typically include global or summary
ratings of multiple scales or health profile approaches. In contrast,
condition-specific measures of HrQoL address the challenges
associated with a particular illness, such as cancer. Since our target
population in this study was children aged 5–18 years, we decided
to use the Pediatric Quality of Life Inventory (PedsQL). PedsQL is
available in two generic instruments; one that comprises 23 items
(PedsQL) with forms for adult (over 26 years), young adult (18–25
years), adolescent (13–18 years), child (8–12 years), young child (5–
7 years) and toddler (2–4 years) and a shorter instrument with 15
items (PedsQL 4.0 SF15) which has forms for adolescent, child,
young child, and toddler. Furthermore, there are PedsQL disease-
specific modules including modules for arthritis, asthma, cerebral
palsy, cardiac, diabetes, family impact, family information, oral
health and transplant among others (http://www.pedsql.org/
[26]). The validity and reliability of the instrument have been
confirmed as a population health measurement tool and in
different child populations with chronic illnesses in descriptive and
evaluative studies [27–30]. The PedsQL has been used in children
with different debilitating conditions such as those associated with
asthma, transplant recipients, attention-deficit hyperactivity disor-
der (ADHD) and neuromuscular disorders [31–34].
The present study evaluated health related quality of life
(HrQoL) in children living in a S. haematobium endemic area in
coastal Kenya, and determined the utility of the pediatric quality
of life inventory short form (PedsQL 4.0 SF15) in assessing
HrQoL. Additionally, we determined the impact of local
transmission features and socioeconomic standing, which are
considered potentially important modifiers of S. haematobium–
related disease burden.
Methods
Ethics statement and eligibility criteria
Ethical clearance was obtained by the Institutional Review
Board at the University Hospital Case Medical Center of
Cleveland and the Ethical Review Committee of the Kenya
Medical Research Institute (KEMRI). Children were eligible if
they were residents of the area for at least two years, were between
5–18 years old, and had provided child assent and written parental
consent.
Study area and population
The study population comprised children aged 5–18 years old.
who participated in both parasitological and nutritional studies in
the five selected endemic rural villages (Milalani, Magadzoni,
Gwadu, Dzitenge and Kinango A) in the three districts
(Msambweni, Kinango, and Kwale) of Kwale County in Coast
Province, Kenya [10,35–37] (Figure 1). This sub-study was
embedded in a larger study of the ecology of transmission of
Author Summary
Because urogenital schistosomiasis is a multi-decadal
chronic disease that begins in early childhood, and
because it is a disease that may affect nearly everyone in
endemic communities, its impact on personal health-
related quality of life (HrQoL) has been difficult to gauge
accurately. In order to provide a more precise estimate of
schistosomiasis’ impact on overall health status, we used a
standardized questionnaire, the PedsQL SF15 Inventory, to
interview children, aged 5–18 years, and their parents, to
quantify their reported physical, social, emotional, and
scholastic performance status. Scores were significantly
lower in villages having high Schistosoma prevalence, as
compared those having moderate prevalence. In adjusting
for age, sex, socioeconomic standing, undernutrition,
anemia, and hookworm parasites, we found that relative
poverty, stunting, wasting, and S. haematobium infection
were significant correlates of HrQoL scores, with differen-
tial effects in high- and moderate-prevalence communities.
The greatest differences were noted in the psychosocial
domains of performance. We conclude that exposure to
urogenital schistosomiasis has an overall detrimental effect
on HrQoL at a level of 2–4% impairment. New implemen-
tation of better diagnostics for children is expected to
refine our estimates of this association, as will follow-up
studies of HrQoL following effective individual and
community deworming.
Quality of Life with Urogenital Schistosomiasis
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vector-borne parasitic infections (the ‘Polyparasitism Project’).
This project enrolled participants through house-to-house demo-
graphic surveys in May–June 2009 for Milalani and in June, July,
August and August–September 2010 for Gwadu, Dzitenge,
Kinango A, and Magadzoni, respectively. Parasitological testing
and anthropometric measurements were conducted simultaneous-
ly in July–August 2009 for Milalani, in October–November 2010
for Gwadu, Dzitenge, and Kinango A, and in April–May 2011 for
Magadzoni. Treatment for any parasite infections detected during
survey testing was provided immediately after the completion of
each village survey. Due to logistical constraints, the PedsQL 4.0
SF15 questionnaires (see below) were administered at varying (3–
16 month) intervals afterwards: in December 2010 for Milalani, in
April–May 2011 for Gwadu, Dzitenge, and Kinango A, and in
July 2011 for Magadzoni.
The numbers of participants per village at enrolment, at
parasitological testing/anthropometric assessment, and at HrQoL
assessment are detailed in Figure 2. All children with full
parasitological and anthropometric results were eligible for
inclusion in the study. For Milalani and Magadzoni villages, we
randomly selected 92 children who had been S. haematobium egg-
positive and 91 who had been S. haematobium egg-negative in each
community for PedsQL 4.0 SF15 tool administration. For the
other villages, we targeted all eligible children, irrespective of their
initial egg-output status, for PedsQL 4.0 SF15 administration.
Parasitological methods
Subjects submitted one midday sample for examination for S.
haematobium infection. Ten-milliliter aliquots from well-mixed urine
samples were subjected to standard Nucleopore filtration [38]. A
single stool examination by Kato-Katz method [39] was used to
identify infection by hookworm and other soil-transmitted
helminths. All children included in this analysis provided finger
prick blood for hemoglobin (Hb) measurement (Hemocue,
A¨ngelholm, Sweden) [10]. Anemia was categorized according to
WHO criteria by age and sex [40]– for ages ,12 years,
Hb,11.5 g/dL; for ages $12 years, Hb,12 g/dL; but for males
$15 years, Hb,13 g/dL.
Anthropometric measurement
Our standardization and measurement procedures used for
anthropometric assessments have been detailed elsewhere (Bus-
tinduy, et al., [10]). The nutritional indicators; height-for-age
(HAZ) and body-mass index (BMI)-for-age (BAZ) were computed
using the World Health Organization’s Anthro-Plus software for
ages 5–19 years (WHO, Geneva, Switzerland) based on reference
growth standards from the year 2006 [41,42]. Stunting and
wasting were defined for values#22 for HAZ and BAZ,
respectively, according to WHO standards [43].
HrQoL measurements
The PedsQL 4.0 SF 15 used in this study includes parallel child
self-reports (age range 5–18 years) and parent proxy-reports. It
differs from PedsQL 4.0 generic core scales instrument by the
number of items in the total scale and in the various subscales. The
PedsQL 4.0 SF15 consists of 5, 4, 3, and 3 for physical, emotional,
social and school functioning respectively, making a total scale of
15 items whereas the PedsQL 4.0 generic core scale comprises of
8, 5, 5, and 5 for physical, emotional, social and school
functioning, respectively, for a total of 23 items. Details are
available at http://www.pedsql.org/about_pedsql.html.
Figure 1. Map of the study area showing location of study villages in Coast Province, Kenya.
doi:10.1371/journal.pntd.0002106.g001
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The survey’s preliminary instructions indicate to the subject that
survey questions ask how much of a problem each item has been
during the past one month. A five-point Likert-like response scale
is used. The response scale for each item was ‘‘never’’ (0), ‘‘almost
never’’ (1), ‘‘sometimes’’ (2), ‘‘often’’ (3), and ‘‘almost always’’ (4).
Responses were transformed to 100, 75, 50, 25, and 0,
respectively, resulting in a scale range of 0–100, with the higher
number scores indicating better HrQoL.
Overall scores and sub-scale scores were computed as the sum
of the items divided by the number of items answered (this
accounts for missing data). If more than 50% of the items in the
scale were missing, the scale score was not computed [44]. Two
summaries and one overall score were computed. Of note, the
physical health summary score (5 items) is the same as the physical
functioning subscale. The psychosocial health summary score (10
items) is computed as the sum of items divided by the number of
items answered in the emotional, social, and school functioning
subscales. Total Scale Scores for child self-report and parent
proxy-report are also presented.
In preparation for the study, two forward translations (English-
Swahili) and one backward translation (Swahili-English) transla-
tions were done for the PedsQL 4.0 SF15. The approved final
Swahili translations of the PedsQL 4.0 SF15 were first pre-tested
on 23 young children (5–7 years old), 39 children (8–12 years old)
and 36 teens and their parents from a neighboring village. These
were all non-participants in the present study but similar to those
included in this study. The illiteracy levels in the study area were
estimated at about 60% and thus the PedsQL 4.0 SF15 instrument
was interview administered [21,45] for both children and their
parents. All the PedsQL 4.0 SF15 questionnaires in this study were
administered by two well-trained research assistants who were
native speakers of Swahili, under the supervision of the first
author.
Statistical analysis
Biological, demographic, parasitological, anthropome-
tric and socioeconomic data. Statistical analyses were con-
ducted using both SPSS for Windows, version 19.0 (SPSS, Inc.,
Chicago, IL) and SAS for Windows, version 9 (SAS Institute Inc.,
Cary, North Carolina). For estimation of socioeconomic standing
(SES) we used housing conditions and household ownership of
selected assets to construct an asset index based on principal
component analysis (PCA) [46]. Participating households were
divided into two equal sized groups (low and higher socioeconomic
standing) according to their scores from the principal components
analysis. The assets included in the PCA were radio, bicycle,
television, telephone, and land. Other indicators of SES included
available household source(s) of cooking fuel, lighting, and
drinking water, type of latrine owned and its distance from the
house, and level of education of the household head.
Chi-square tests were used to test for differences in proportions,
and the Mann-Whitney U test was used to assess differences in
Figure 2. Flow chart of study participation. Numbers of children by village at enrolment, at parasitological and anthropometric testing, and at
HrQoL assessment.
doi:10.1371/journal.pntd.0002106.g002
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intensities of infection, age, and Hb. Analysis of variance
(ANOVA) was used to compare infection intensity among villages.
Analysis of HrQoL data
Feasibility of the PedsQL 4.0 SF15 generic version was
determined from the average percentage of missing responses. The
percentage of all possible item responses left unanswered was
calculated for each subject on each single and summary scale and
averaged over subjects.
Utility of the instruments in terms of distributional coverage
overall and by subscale was evaluated by calculating the
percentage of subscale-level average responses reaching the
minimum (floor) or the maximum (ceiling) of the scoring scale.
In QoL studies, floor and ceilings effects are used to evaluate the
depth of a health problem being measured. If floor effects exist, it
means the QoL tool is showing a lower than actual HrQoL, and if
ceiling effects exist, QoL tools may be underestimating QoL or the
magnitude of the problem being measured. Studies with small
floor or ceiling effects (1–15%) are considered to meet acceptable
measurement standards, whereas studies with moderate floor or
ceiling effects (.15%) are considered less precise in measuring
latent constructs at the extremes of the scale [25,47].
Internal consistency is a measure of the extent to which
items in a questionnaire (subscale or scale) are correlated
(homogeneous), thus measuring the same concept. It is an
important measurement property for questionnaires that intend
to measure a single underlying concept (construct) by using
multiple items such as PedsQL questionnaire. Cronbach’s alpha
coefficient was utilized to determine scale internal consistency
reliability [48]. Scales with reliabilities of 0.70 or greater are
recommended for comparing patient groups, while a reliability
criterion of 0.90 is recommended for analyzing individual patient
scores [49]. A low Cronbach’s alpha indicates a lack of correlation
between the items in a scale, which makes summarizing the items
unjustified. A very high Cronbach’s alpha (.0.95) indicates high
correlations among the items in the scale, i.e., redundancy of one
or more items [25]. Construct validity was determined utilizing the
known-groups method, which compares scale scores across groups
known to differ in the health construct being investigated. In our
study the known groups are the children who tested positive and
negative for S. haematobium egg output, who will henceforth be
referred to as ‘Sh egg-positive’ and ‘Sh egg-negative’, respectively.
Known groups validity was examined through a comparison of
these egg-positive and egg-negative groups, of children from
families of lower versus higher SES, of stunted versus non-stunted
children, and those from high prevalence (high risk) villages versus
moderate prevalence (lower risk) villages, using independent t-tests.
To complement statistical testing, effect sizes are presented to
assist in the interpretation of the relative degree of between-group
score differences by indexing these differences to within-group
score variation [50], with lesser import if the between-group score
difference is small relative to the within-group variation in scores.
Effect size utilized in these analyses was calculated by taking the
difference between the score means for either cases vs. controls,
stunted vs. non-stunted children, children from low SES vs. high
SES, or children from high-risk vs. moderate risk villages, divided
by the pooled standard deviation of the egg-negative/high SES/
not stunted/lower-risk village categories, as appropriate [51].
Effect sizes for differences in means are designated as small (0.20–
0.49), medium (0.50–0.79), and large ($0.80) in magnitude [52].
Agreement between child self-report and parent proxy-report was
determined through 2-way mixed-effect model (absolute agree-
ment, single measure) intraclass correlations [53]. Intraclass
correlation results are generally interpreted as follows: #0.40,
poor to fair agreement; 0.41–0.60, moderate agreement; 0.61–
0.80, good agreement; and 0.81–1.00, excellent agreement [54].
Multivariable modeling of HrQoL outcomes
Following our observation of significant differences in group-
wise mean HrQoL scores in the analyses described above, our next
objective was to determine the independent contributions of age,
sex, village risk for schistosomiasis (high vs. moderate), S.
haematobium infection, hookworm infection, anemia, SES, stunting,
and wasting in nested models of HrQoL outcomes, for both total
and psychosocial sub-scale scores. To do this, we used generalized
multivariable linear modeling, adjusted for covariance at the
village level using generalized estimating equation (GEE) tech-
nique (SPSS). Stepwise backward removal of non-significant
variables was used to create ‘best fit’ parsimonious models based
on Akaike information criteria (AIC) retaining explanatory
variables with P-values,0.1. Significant multiply-adjusted param-
eter estimates are reported (with 95% CI and corresponding p-
values) for covariates remaining in the final models.
Results
Study group characteristics
In total, 1580 children, aged 5–18 years old, from five villages
participated in parasitological and anthropometric testing. Their
mean age was 10.663.5 and 51% were female. The majority of
the children in Milalani, Magadzoni, and Gwadu (the more rural
villages) came from families of low SES while most children in
Kinango A and Dzitenge (the more urban villages) came from
families of higher SES (Table 1, Figure 1).
Parasitology
The overall S. haematobium infection prevalence was 42.2% (766/
1580), similar for males and females, but significantly different by
village (Table 1) and by age group (Table 2). School-age infection
prevalence was significantly greater in Milalani, and Gwadu
villages (here referred to as high-prevalence villages, according to
WHO guidelines [55]) compared to Magadzoni, Dzitenge, and
Kinango A villages (here referred to as moderate prevalence
villages). S. haematobium infection intensity was highest in 8–12 year
olds and lowest in 5–7 year olds (P,0.01, Table 2), and varied
significantly by village (Table 1) with an overall geometric mean
intensity of infection of 37.8 eggs/10 mL of urine. Males had
significantly heavier infection than females (P,0.02). There were
also significant inter-village and across-age group differences in the
proportion of anemic children and in mean Hb levels (Tables 1
and 2).
Anthropometric outcomes
Many study children had either acute undernutrition, as
measured by wasting (BAZ score #22), chronic undernutrition,
as measured by stunting prevalence (HAZ score #22), or both.
The highest malnutrition levels were recorded in villages closer to
the coastline (Milalani, Magadzoni, and Gwadu) compared to the
more inland villages (Dzitenge and Kinango A) (Table 1). Wasting
and stunting were lowest in the 5–7 year age group compared to
older age groups (Table 2). Significantly more males were stunted
(56% vs. 44%, X2 = 9.2, P,0.01) or wasted (60% vs. 40%%,
X2 = 14.8, P,0.001) as compared to females.
HrQoL analysis
Participation. The PedsQL SF15 tool was administered to
835 children and 800 of their parents. Overall, missing responses
were found for 33 children (4.0%) and 35 parents (4.4%), yielding
Quality of Life with Urogenital Schistosomiasis
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802 and 765 children and parents with complete HrQoL data,
respectively (Table 3). The distribution of 802 children who had
complete HrQoL data by village and age groups is shown in
Figure 2.
Feasibility. Table 3 shows the missing responses, and the
floor and ceiling effects noted in the PedsQL 4.0 SF15
administration in our study area. Missing values were found in
both child self-report (range: 0.0–5.4%) and parent proxy-reports
(range: 0.2–4.4%). The school function scale had the highest
missing values for both self and parent proxy-reports (Table 3).
Floor effects were found in both self and parent-proxy reports
(range: 0.0–1.3). Influential ceiling effects (i.e., .15%) were found
in the physical, social, and school function scales in self report,
with highest values noted for the school function scale. Relevant
ceiling effects were found in all scales in the parent proxy report
except for the total scores (Table 3).
Internal consistency of the questionnaire. The internal
consistency/reliability alpha coefficients are presented for the
PedsQL SF15 in Table 4. All the parent proxy-report scales
exceeded the minimum internal consistency reliability standard
(0.70) required for group comparisons for all ages. In child self-
reports, reliability coefficients for most PedsQL SF15 scales
approached or exceeded the recommended standard of 0.70 for
group comparison (Table 4).
Parent-child concordance. Table 5 presents the intraclass
correlations (ICCs) between child self-reports and parent proxy-
reports of the PedsQL SF15 scales. Fair to good agreement was
found in the generic core scales of both the S. haematobium egg-
positive and egg-negative (control) groups. ICCs were generally
higher in the control group. Lower correlation values were
obtained in the social function scales across all age groups, and in
the physical scale in 5–7 year olds. Children and their parent
proxies consistently showed good to excellent agreement for school
and psychosocial scales across all age groups.
HrQoL outcomes according to location, infection status,
SES, and known morbidities. To assess the impact of
exposure to urogenital schistosomiasis, we examined differences
in observed PedsQL SF15 outcomes on several levels—high-
prevalence vs. moderate-prevalence villages, S. haematobium egg-
positive vs. egg-negative individuals, and according to cofactors
likely to influence HrQoL (presence or absence of lower SES,
anemia, or undernutrition). The most striking finding was the
significantly higher HrQoL scores reported by both children and
parent residing in moderate risk villages as compared to those
from high risk villages (Figure 3). Furthermore, within the
moderate risk villages, when comparing PedsQL SF15 scores,
egg-negative children had significantly higher HrQoL in all scales
except physical and school scales (for both child-self and parent-
proxy reports), with effect sizes mostly in the medium range
(Table 6). Of note, the PedsQL SF15 egg-positive vs. egg-negative
score differences within the high risk villages were small and not
significant, and mostly in the opposite direction for most scales
(Table 6).
For all PedsQL SF15 scales (except physical functioning in
parent proxy-report) children who tested negative for S. haemato-
bium egg output and their parents reported better HrQoL than
those who tested egg-positive during parasitological examination
(Table 7). However, for the overall combined village data, where
the largest effect size observed for the social subscale (0.21), none
of these group-wise differences in child self-report was statistically
significant. Parents of egg-negative children reported better
HrQoL scores for their children compared to parents of egg-
positive cases for all subscales, except in the physical subscales.
These parental HrQoL scores were only statistically different
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for the social scale, and effect sizes were generally of small
magnitude.
For stunting, all scales reported lower quality of life in stunted
children, with significant differences in psychosocial and total
scales in self-reports, and in the school functioning scale in the
proxy-report (see Supporting Information, Table S1). In both child
self and parent proxy reports, lower SES was significantly
associated with lower HrQoL in all scales except the physical
functioning, with effect sizes mostly in medium to high range (see
Supporting Information, Table S2). Within the low SES group,
when comparisons were made between egg-positive and egg-
negative children, egg-positives reported lower HrQoL compared
to controls. However, when similar comparisons were made within
the higher SES group, the differences were very small and
inconsistent, with some scales reporting higher HrQoL among
egg-positive children (data not shown).
Given the group-wise differences observed above, we next used
a Generalized Estimating Equation (GEE) multivariable analysis
to account for possible confounding and/or effect modification of
score outcomes caused by varied distribution of subject classes
across villages and infection status groups. As noted in Tables 8
and 9, HrQoL total scores and psychosocial sub-scores were
significantly lower in high-prevalence villages, even with adjust-
ment for SES, sex, and/or age. Not shown, hookworm infection
Table 2. Characteristics of the study population by age group.
5–7 years (n=358) 8–12 years (n=716) 13–18 years (n =506) P valuea
Mean age (SD) 6.160.8 10.061.4 14.661.5 –
% Female 48.3 53.2 50.6 .0.2
% Lower SES 55.3 50.4 50.0 .0.2
Sh+ prevalence 33.0 42.0 48.8 ,0.001
Sh+ geometric mean intensity (eggs/10 ml of urine) 28.7 48.7 31.2 ,0.05
% Anemicb 36.9 33.5 40.5 ,0.05
Mean hemoglobin, g/dl (Range) 11.9 (4.3–16.5) 12.1 (4.6–17.4) 12.4 (5.2–17.5) ,0.001
% Stuntedc 17.3 30.2 36.6 ,0.001
% Wastedd 7.0 14.4 17.8 ,0.001
Abbreviations: SD, standard deviation; SES, socioeconomic standing; Sh+, Schistosoma haematobium egg-positivity.
aP value refers to significance of differences among the villages by Mann-Whitney U test, ANOVA, or chi-square testing.
bAnemia based on WHO age-specific hemoglobin (Hb) criteria [40]: for ages ,12 years, Hb,11.5 g/dl; for ages $12 years, Hb,12 g/dl; but for males $15 years,
Hb,13 g/dl.
cStunting: in height-for-age Z score (HAZ)#22.
dWasting: BMI-for-age Z score (BAZ)#22.
doi:10.1371/journal.pntd.0002106.t002
Table 3. Feasibility and utility of PedsQL SF15 for children initially S. haematobium egg-positive or egg-negativea.
Scale # items Egg-positive (n =352) Egg-negative (n=450) Overall (n = 802)
% Missing % Floorb % Ceilingb % Missing % Floor % Ceiling % Missing % Floor % Ceiling
Child self-report
Physical functioning 5 0.3 0.0 71.0 0.6 0.2 71.6 0.5 0.1 71.3
Emotional functioning 4 0.0 0.0 8.5 0.9 0.0 14.7 0.5 0.0 12.0
Social functioning 3 0.0 0.0 27.6 0.2 0.4 34.7 0.1 0.2 31.5
School functioning 3 3.3 1.1 74.4 2.8 1.3 77.8 3.0 1.2 76.3
Psychosocial score 10 3.3 0.0 5.1 3.6 0.0 9.6 3.5 0.0 7.6
Total scores 15 3.6 0.0 4.5 4.3 0.0 8.0 4.0 0.0 6.5
Parent proxy-report n =333 n=432 n=765
Physical functioning 5 0.3 0.0 78.1 0.7 0.2 74.5 0.5 0.1 76.1
Emotional functioning 4 0.0 0.0 20.1 0.9 0.2 25.9 0.5 0.1 23.4
Social functioning 3 0.0 0.0 35.4 0.2 0.0 45.1 0.1 0.0 40.9
School functioning 3 4.8 0.0 46.8 2.0 0.2 50.2 3.3 0.1 48.8
Psychosocial score 10 4.8 0.0 12.6 3.1 0.0 17.6 3.9 0.0 15.4
Total scores 15 5.1 0.0 12.6 3.8 0.0 15.7 4.4 0.0 14.4
aCases were those children initially found to have S. haematobium eggs on urine filtration during parasitological surveys. Controls were children who had been egg-
negative. N.B. The PedsQL SF15 was administered 3–16 months after completion of testing and treatment for infection.
b% Floor/Ceiling = the percentage of scores at the extremes of the scaling range. Floor or ceiling effects in the range of 1–15% are acceptable while those .15% [in
BOLD] are considered to provide less precise estimates.
doi:10.1371/journal.pntd.0002106.t003
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or intensity did not have a significant effect on Peds QL scores
when adjusted for other factors in the model. Variable interaction
terms for village type were highly significant, leading to a
stratified village type analysis also presented in Tables 8 and 9. In
high-prevalence villages, lower SES, and stunting were signifi-
cantly associated with lower total and psychosocial scores,
whereas wasting and S. haematobium egg-positivity were associated
with higher scores. In moderate-prevalence villages, S. haemato-
bium egg positivity was the sole significant correlate of total
HrQoL score, reducing it by an estimated 2.1%. For the
psychosocial sub-scale, egg-positivity contributed on a similar
level (22.4%) to a lower score, while being in the 8–12 year old
age group was associated with a significantly slightly better score
(+0.8%).
Table 4. Internal consistency reliability in self-report and parent proxy-report– Cronbach alpha statisticsa within different survey
domains.
Scale
Young children
(5–7 years) Children (8–12 years)
Adolescent
(13–18 years) Overall
Casesb Controlsb Cases Controls Cases Controls Cases Controls
Child self-report n =84 n=109 n=147 n=200 n=121 n=141 n=352 n=450
Physical functioning 0.86 0.89 0.86 0.87 0.83 0.87 0.85 0.87
Emotional functioning 0.79 0.81 0.76 0.82 0.74 0.80 0.76 0.81
Social functioning 0.83 0.85 0.79 0.82 0.76 0.80 0.79 0.82
School functioning 0.84 0.86 0.84 0.85 0.83 0.83 0.83 0.85
Psychosocial score 0.73 0.77 0.70 0.75 0.66 0.73 0.69 0.74
Total scores 0.72 0.76 0.68 0.73 0.64 0.71 0.67 0.73
Parent proxy-report n =80 n=105 n=139 n=192 n=114 n=135 n=333 n=432
Physical functioning 0.88 0.90 0.87 0.90 0.87 0.87 0.87 0.89
Emotional functioning 0.84 0.80 0.78 0.86 0.83 0.84 0.81 0.84
Social functioning 0.88 0.82 0.80 0.87 0.87 0.86 0.85 0.86
School functioning 0.86 0.87 0.85 0.87 0.86 0.86 0.86 0.87
Psychosocial score 0.79 0.77 0.72 0.80 0.78 0.78 0.76 0.79
Total scores 0.78 0.75 0.71 0.79 0.77 0.77 0.75 0.78
aCronbach alpha values $0.70 are recommended for comparing patient groups, and $0.90 are recommended for analyzing individual patient scores [49].
bCases were those children initially found to have S. haematobium eggs on urine filtration during parasitological surveys. Controls were children who had been egg-
negative. N.B. The PedsQL SF15 was administered after testing and treatment for infection.
doi:10.1371/journal.pntd.0002106.t004
Table 5. Agreement between self-report and parent proxy-report PedsQL SF15 score scales.
Young children (5–7 years) Children (8–12 years) Teens (13–18 years) All ages
Sha egg-positive
Physical functioning 0.09 0.51 0.55 0.47
Emotional functioning 0.41 0.23 0.38 0.34
Social functioning 0.19 0.20 0.13 0.18
School functioning 0.56 0.49 0.58 0.54
Psychosocial score 0.93 0.90 0.92 0.92
Total scores 0.30 0.30 0.50 0.37
Sh egg-negative
Physical functioning 0.37 0.49 0.40 0.44
Emotional functioning 0.40 0.40 0.34 0.41
Social functioning 0.37 0.28 0.47 0.39
School functioning 0.64 0.60 0.63 0.65
Psychosocial score 0.94 0.93 0.95 0.94
Total scores 0.57 0.47 0.52 0.55
Inter-class correlation (ICC) values for survey results are considered as poor to fair agreement (#0.40), moderate agreement (0.41–0.60), good agreement (0.61–0.80) or
excellent agreement (0.81–1.00) [54]. Bold face indicates moderate or better agreement between child and parent-proxy.
aAbbreviation: Sh, Schistosoma haematobium.
doi:10.1371/journal.pntd.0002106.t005
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Discussion
This is a first attempt to measure self-rated multidimensional
HrQoL related to urogenital schistosomiasis in children. In our
initial analysis, we observed a clear trend toward lower HrQoL in
all measurement scales (except physical scale) among children with
S. haematobium egg-positive status, but the differences were not
significant. This trend was confirmed in parent-proxy reports,
which indicated the same trend in all performance scales, and for
the social scale, parents of egg-positive children did report
significantly lower HrQoL scores than parents of egg-negative
children. Significant differences were observed in other group-wise
analysis, indicating lower HrQoL for children resident in high-S.
haematobium prevalence villages as compared to those living in
moderate-prevalence villages, and significantly lower HrQoL for
children with growth stunting.
Previous investigations described strong associations between
growth stunting and low intensity Schistosoma infections [6,56–58];
Figure 3. PedsQL SF15 score scales contrasting high and moderate risk villages for self and proxy reports. Abbreviations: Phy-Physical;
Emo-Emotional; Soc-Social; Sch-School; Psy-Psychosocial, Tot-Total. NS-Not significant; **P,0.001; ***P,0.0001.
doi:10.1371/journal.pntd.0002106.g003
Table 6. PedsQL SF15 score scales for children and parents within high and moderate prevalence villages.
High Prevalence Moderate Prevalence
Sh egg +vea Sh egg 2vea Effect size Sh egg +ve Sh egg 2ve Effect sizeb
Scale Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Child self-report n= 241 n= 260 n = 111 n = 190
Physical functioning 96.0 (9.5) 95.1 (11.2) 20.08 93.6 (13.8) 95.7 (12.2) 0.20
Emotional functioning 63.7 (19.5) 63.2 (19.5) 20.04 66.7 (17.8) 71.3 (20.5)* 0.44
Social functioning 75.2 (20.4) 75.0 (21.3) 20.02 83.2 (14.1) 86.9 (14.6)* 0.35
School functioning 84.8 (17.3) 84.5 (19.9) 20.03 88.7 (15.8) 88.8 (15.5) 0.09
Psychosocial score 73.5 (13.5) 73.1 (14.6) 20.04 78.3 (11.2) 81.3 (12.8)* 0.29
Total scores 81.0 (9.7) 80.4 (10.9) 20.05 83.4 (9.7) 86.1 (10.5)* 0.26
Parent proxy-report n= 225 n= 249 n = 108 n = 183
Physical functioning 96.1 (11.7) 95.2 (12.0) 20.07 94.1 (14.6) 94.9 (13.2) 0.07
Emotional functioning 70.5 (23.8) 69.6 (25.1) 20.07 72.1 (19.4) 77.7 (17.9)* 0.51
Social functioning 82.3 (17.1) 83.5 (17.8) 0.10 84.9 (13.9) 88.3 (14.4)* 0.31
School functioning 84.9 (20.1) 86.2 (19.5) 0.10 86.8 (17.6) 86.7 (19.3) 20.09
Psychosocial score 79.3 (14.7) 79.7 (15.6) 0.17 81.3 (11.7) 84.2 (12.9)* 0.27
Total scores 84.3 (11.7) 84.2 (12.4) 20.06 84.9 (10.9) 87.3 (10.9) 0.22
aSh egg +ve were those children initially found to have S. haematobium eggs on urine filtration during parasitological surveys. Sh egg 2ve were children who had been
egg-negative. N.B. The PedsQL SF15 was administered after testing and treatment for infection.
bEffect size = (difference between cases and controls)/SD of controls. Effect sizes are designated as small (.20), medium (.50), and large (.80).
*p,0.05 (independent samples t-test).
doi:10.1371/journal.pntd.0002106.t006
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thus the joint association of lower HrQoL with local prevalence
and stunting was an expected finding. Our results are in contrast
to recent studies of other NTDs that suggest no clear differences in
HrQoL between infected and non-infected health states [14,16].
Increasing severity of intestinal schistosomiasis, whether caused by
S. japonicum in P.R. China [13,15] or by S. mansoni in Egypt [20],
has been associated with significantly greater reductions in self-
reported quality of life scores. It is possible that inclusion of a
larger range of age-groups, and patients with more advanced
complications of S. haematobium would have resulted in more
pronounced differences in our observed outcomes. We found
significant associations between either i) lower socio-economic
status, or ii) residence in high risk villages, with lower PedsQL 4.0
SF15 scores across all scales, except for physical and school
functional scales. Socio-economic status is known to affect the risk
of Schistosoma infection by either limiting water-use options and/or
access to health care, or through other poverty-related factors
[11,57,59,60].
In our study, the initial lack of significant differences in HrQoL
between children with and without egg output could be attributed
Table 7. PedsQL SF15 scores for study participants stratified according to S. haematobium egg-positive vs. egg-negative status.
Scale # items Sh egg-positive
a Sh egg-negativea Difference Effect Sizeb t score P valuec
n Mean SD n Mean SD
Child self-report
Physical functioning 5 352 95.3 11.1 450 95.4 11.6 0.1 0.09 0.07 .0.5
Emotional functioning 4 352 64.7 19.0 450 66.6 20.3 1.9 0.17 1.39 .0.1
Social functioning 3 352 77.7 19.0 450 80.0 19.7 2.3 0.21 1.65 .0.05
School functioning 3 352 88.3 22.4 450 89.0 22.6 0.7 0.06 0.45 .0.5
Psychosocial score 10 352 76.1 12.7 450 77.7 14.2 1.6 0.14 1.58 .0.1
Total scores 15 352 81.8 9.8 450 82.8 11.1 1.0 0.09 1.43 .0.1
Parent proxy-report
Physical functioning 5 333 95.4 12.7 432 95.1 12.5 20.3 20.03 20.41 .0.5
Emotional functioning 4 333 71.1 22.5 432 73.0 22.6 1.9 0.16 1.18 .0.2
Social functioning 3 333 83.2 16.2 432 85.5 16.6 2.3 0.20 1.97 ,0.05
School functioning 3 333 85.5 19.3 432 86.4 19.4 0.9 0.08 0.63 .0.5
Psychosocial score 10 333 79.9 13.8 432 81.6 14.7 1.7 0.14 1.66 .0.1
Total scores 15 333 84.5 11.5 432 85.5 11.8 1.0 0.09 1.22 .0.2
aSh egg-positive were those children initially found to have S. haematobium eggs on urine filtration during parasitological surveys. Sh egg –negative were children who
had been egg-negative. N.B. The PedsQL SF15 was administered after testing and treatment for infection. (n = 802 for child self-report and 765 for parent proxy report).
bEffect size = (difference between cases and controls)/SD of controls. Effect sizes are typically designated as small (0.20–0.49), medium (0.50–0.79), or large ($0.80).
cP,0.05 (independent sample t-test).
doi:10.1371/journal.pntd.0002106.t007
Table 8. Multivariable GEE modeling of self-reported total HrQoL scores adjusting for measured covariatesa.
Combined villages High Sh prevalence villages Moderate Sh prevalence villages
Variable
Parameter Estimate
(95% CI) P value
Parameter Estimate
(95% CI) P value
Parameter Estimate
(95% CI) P value
High prevalence village 24.0 (24.9, 23.2) ,0.001 – – – –
Sex = Female 20.18 (23.2, 20.04) ,0.05 – – – –
Lower SESb 22.0 (24.0, 20.06) ,0.05 24.1 (25.8, 22.4) ,0.001 – –
Stuntingc 21.2 (22.6, 0.12) .0.05 23.1 (24.2, 22.0) ,0.001 – –
Wastingd – – +3.1 (2.6, 3.6) ,0.001 – –
Sh egg-positive on initial survey – – +2.4 (0.2, 4.6) ,0.05 22.1 (23.9, 20.28) ,0.05
In each case, the initial model of PedsQL SF15 score included the following explanatory variables: sex, age group, village type (high- vs. lower-endemicity),
socioeconomic standing, current Schistosoma infection, current hookworm infection, anemia, presence of growth stunting, and nutritional wasting. Generalized
multivariable linear modeling, adjusted for covariance at the village level using GEE estimation (SPSS) used stepwise backward removal of non-significant variables to
create ‘best fit’ parsimonious models (based on information criteria) retaining explanatory variables with P-values,0.1. Multiply-adjusted parameter estimates are
reported (with 95% CI and corresponding P-values) for covariates remaining in the final models. Scale for the HrQoL scale output variable was set at 100, so that the
parameter estimates reflect percentage changes in overall HrQoL as estimated by the PedsQL instrument.
aAbbreviations: GEE, Generalized Estimating Equations; HrQoL, Health-related quality of life; Sh, Schistosoma haematobium; CI, Confidence Interval; SES, socio-economic
standing.
bReference group for comparison was top 50% SES.
cStunting: height-for-age Z score (HAZ) #22.
dWasting: BMI-for-age Z score (BAZ) #22.
doi:10.1371/journal.pntd.0002106.t008
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to confounding by the distribution of low SES and undernutrition
across the village levels. Our multivariable analysis indicated a
strong village-type effect (with high-prevalence status having
significantly lower HrQoL scores), but with significant interaction
between village type and all other covariates tested. A further
stratified analysis indicated that S. haematobium egg positivity was
significantly associated with reduced HrQoL in moderate preva-
lence villages, whereas in high-prevalence villages, it was
associated with higher HrQoL. This difference is likely to reflect
issues with the imperfect sensitivity of our standard parasitological
diagnosis of urogenital schistosomiasis (urine egg output [61]), and
covariation between age- and SES-related infection risk. In
addition, for schistosomiasis and other neglected tropical diseases,
the time from the onset of active infection to the onset of clinical
disease may be protracted. Also, a single urine exam may miss 20–
30% of active infections that would be found by repeated urine
exams [61]. Serological testing indicates that among children in
high-prevalence villages, active or recent Schistosoma infection
prevalence is close to 100% [23]. Light intensity infections are
more easily missed in parasitological testing. However, these can
still result in significant inflammation-mediated morbidity. We
believe that in high-prevalence villages, infection status is already
saturated, so that egg-positivity reflects mainly those with heavier
infections. In the high-prevalence setting, this sub-group includes
older children with greater mobility [62], who may therefore have
better scores on the PedsQL scales. In moderate prevalence
villages, where egg testing is more likely to reliably distinguish
infected and uninfected children, S. haematobium egg-positivity was
significantly associated with lower HrQoL scores. Overall,
uncertainty (negative study bias) about the status of egg-negative
controls may explain why we observed significant ‘infection-
related’ differences in moderate-risk villages but not in high-risk
villages. Finally, because PedsQL 4.0 SF15 questionnaire admin-
istration was not administered at the same time as the
parasitological assessment, some of the ‘controls’ identified during
parasitological assessment may have turned into ‘cases’ (i.e., those
who were now or formerly S. haematobium infected) by the time
HrQoL assessment was done. Because treatment was given before
administration of the Peds QL survey, acute impacts of active
infection may have gone missed, and these may have had an
impact on our study findings. We recommend that similar studies
in future carry both assessments concurrently, and include
supplemental serologies (circulating antigen testing, anti-Schisto-
soma IgG4), in order to minimize the misidentification of the true
infection status of ‘cases’ and ‘controls’.
The mode of administration of the PedsQL 4.0 SF15
questionnaire was interviewer-based; thus, the high response rate
was not surprising. However, it may have contributed to the lack
clear differences between the cases and controls, because
interviewer-based modes of questionnaire administration suffer
from a well- recognized problem of limited willingness to
acknowledge a problem [24]. Since all interviews across all
villages were conducted by two trained research assistants using
one-to-one administration, we believe the interviewer effect was
not significant. For the study children, inclusion of a parent-proxy
survey, in addition to the direct patient survey, was considered to
add external evidence of the validity of the answers we obtained
from the children.
Floor effects were largely absent in the study population, except
in the school scale where negligible (,1.3%) floor effects were
observed, especially among controls. On the other hand,
substantial ceiling effects were evident in almost all scales, and
were more prominent in physical and school scales particularly
among controls (Sh egg - negative). This means that the PedsQL
4.0 SF15 questionnaire likely underestimated HrQoL, especially
for children who tested negative for S. haematobium egg output.
While ceiling effects are a common phenomenon, they restrict the
ability of the HrQoL tool to detect change or describe health
above the average in more healthy populations [16,63–65]
We consider the PedsQL to be a suitable tool for assessing
quality of life in children with schistosomiasis. There is evidence
that its reliabilities were high (alphas generally $0.70), floor effects
Table 9. Multivariable GEE modeling of HrQoL psychosocial scores adjusting for measured covariatesa.
Combined villages High Sh prevalence villages Moderate Sh prevalence villages
Variable
Parameter Estimate
(95% CI) P value
Parameter Estimate
(95% CI) P value
Parameter Estimate
(95% CI) P value
High prevalence village 25.7 (26.7, 25.0) ,0.001 – – – –
Lower SESb 22.9 (25.0, 20.9) ,0.01 25.0 (26.5, 23.5) ,0.001 – –
Stuntingc 21.4 (22.9, 0.6) .0.05 23.7 (26.7, 20.7) ,0.05 – –
Wastingd +3.9 (3.3, 4.5) ,0.001 – –
Sh egg-positive on initial survey +2.6 (20.5, 5.7) .0.05 22.4 (25.6, 0.7) .0.1
Age 8–12e +0.7 (0.59, 0.83) ,0.001 – – +0.8 (0.07, 1.5) ,0.05
Age 13–18e – – +1.2 (0.4, 2.0) ,0.01 – –
In each case, the initial model of PedsQL SF15 score included the following explanatory variables: sex, age group, village type (high- vs. lower-endemicity),
socioeconomic standing, current Schistosoma infection, current hookworm infection, anemia, presence of growth stunting, and nutritional wasting. Generalized
multivariable linear modeling, adjusted for covariance at the village level using GEE estimation (SPSS) used stepwise backward removal of non-significant variables to
create ‘best fit’ parsimonious models (based on information criteria) retaining explanatory variables with P-values,0.1. Multiply-adjusted parameter estimates are
reported (with 95% CI and corresponding P-values) for covariates remaining in the final models. Scale for the HrQoL scale output variable was set at 100, so that the
parameter estimates reflect percentage changes in overall HrQoL as estimated by the PedsQL instrument.
aAbbreviations: GEE, Generalized Estimating Equations; HrQoL, Health-related quality of life; Sh, Schistosoma haematobium; CI, Confidence Interval; SES, socio-economic
standing.
bReference group for comparison was top 50% SES.
cStunting: height-for-age Z score (HAZ) #22.
dWasting: BMI-for-age Z score (BAZ) #22.
eReference group was 5–7 year olds.
doi:10.1371/journal.pntd.0002106.t009
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were acceptable and identification of children from both low SES
and ‘high risk’ villages was valid. PedsQL 4.0 SF15 was an
effective tool for measuring quality of life in children living in
schistosomiasis- (and likely other neglected tropical disease-)
endemic areas. The clear capability of PedsQL 4.0 SF15 tool to
identify geographical areas with different transmission intensities
and SES groups is particularly important in schistosomiasis
control. In large scale schistosomiasis control programs, its
practicability (administered within 5 minutes) means it can
appropriately be used to rapidly tease out high transmission
localities for further adjustment. However, further research is
needed, especially on its reproducibility and responsiveness (ability
to detect clinically important changes over time) in relation to
schistosomiasis. The difficulties in measuring physical and school
health illustrated here also point to the need for further research
and the development of a schistosomiasis specific PedsQL tool to
enhance assessment of Schistosoma infection-related health impact.
Supporting Information
Checklist S1 STROBE checklist.
(DOC)
Table S1 PedsQL SF15 score scales for stunted children
and non-stunted children.
(DOCX)
Table S2 PedsQL SF15 score scales for children from
lower and higher socioeconomic standing.
(DOCX)
Acknowledgments
The authors want to specially acknowledge our energetic field workers,
Omar Kallam, Joyce Bongo, Phyllis Mutemi, and Nancy Halloway, for
their dedication and meticulous anthropometric measurements. We also
thank the many DVBND laboratory technicians who provided the
parasitology results. We warmly thank the many children and parents of
Milalani, Magadzoni, Gwadu, Dzitenge and Kinango who willingly
participated in the study.
Author Contributions
Conceived and designed the experiments: CCT ALB RVM UK CHK.
Performed the experiments: CCT ALB RVM FMM. Analyzed the data:
CCT UK CHK FMM. Contributed reagents/materials/analysis tools:
CCT ALM RVM NM PLM EMM UK CHK FMM. Wrote the paper:
CCT ALB RVM EMM UK CHK FMM.
References
1. WHO (2012) Schistosomiasis: population requiring preventive chemotherapy
and number of people treated in 2010. Weekly Epidemiological Record 87: 37–
44.
2. El-Khoby T, Galal N, Fenwick A, Barakat R, El-Hawey A, et al. (2000) The
epidemiology of schistosomiasis in Egypt: summary findings in nine governor-
ates. American Journal of Tropical Medicine and Hygiene 62: 88–99.
3. Kapito-Tembo AP, Mwapasa V, Meshnick SR, Samanyika Y, Banda D, et al.
(2009) Prevalence distribution and risk factors for Schistosoma hematobium infection
among school children in Blantyre, Malawi. PloS Neglected Tropical Diseases 3:
e361.
4. Matthys B, Tschannen AB, Tian-Bi NT, Comoe H, Diabate S, et al. (2007) Risk
factors for Schistosoma mansoni and hookworm in urban farming communities in
western Cote d’Ivoire. Tropical Medicine and International Health 12: 709–
723.
5. Satayathum SA, Muchiri EM, Ouma JH, Whalen CC, King CH (2006) Factors
affecting infection or reinfection with Schistosoma haematobium in coastal Kenya:
Survival analysis during a nine-year, school-based treatment program. American
Journal of Tropical Medicine and Hygiene 75: 83–92.
6. King CH, Dangerfield-Cha M (2008) The unacknowledged impact of chronic
schistosomiasis. Chronic Illness 4: 65–79.
7. King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic
helmintic infection: a meta-analysis of disability-related outcomes in endemic
schistosomiasis. Lancet 365: 1561–1569.
8. King CH, Sturrock RF, Kariuki HC, Hamburger J (2006) Transmission control
for schistosomiasis—why it matters now. Trends in Parasitology 22: 575–582.
9. King CH, Olbrych SK, Soon M, Singer ME, Carter J, et al. (2011) Utility of
repeated praziquantel dosing in the treatment of schistosomiasis in high-risk
communities in Africa: a systematic review. PLoS Negl Trop Dis 5: e1321.
10. Bustinduy AL, Thomas CL, Fiutem JJ, Parraga I, Mungai P, et al. (2011)
Measuring fitness of Kenyan children with polyparasitic infections using the 20-
Meter Shuttle Run Test as a morbidity metric. PloS Neglected Tropical Diseases
5: e1213.
11. King CH, Bertino A-M (2008) Asymmetries of poverty: why global burden of
disease valuations significantly underestimate the burden of neglected tropical
diseases. PloS Neglected Tropical Diseases 2: e209.
12. Murray CJL, Lopez AD (1996) The Global Burden of Disease: A Comprehen-
sive Assessment of Mortality and Disability from Diseases, Injuries, and Risk
Factors in 1990 and Projected to 2020. Cambridge MA: Harvard School of
Public Health/World Bank. 990 p.
13. Jia T-W, Zhou X-N, Wang X-H, Utzinger J, Steinmann P, et al. (2007)
Assessment of the age-specific disability weight of chronic schistosomiasis
japonica. Bulletin of the World Health Organization 85: 458–465.
14. Fu¨rst T, Mu¨ller I, Coulibaly JT, Yao AK, Utzinger J, et al. (2011)
Questionnaire-based approach to assess schoolchildren’s physical fitness and
its potential role in exploring the putative impact of helminth and Plasmodium
spp. infections in Coˆte d’Ivoire. Parasites and Vectors 4: 116.
15. Jia T-W, Utzinger J, Deng Y, Yang K, Li Y-Y, et al. (2011) Quantifying quality
of life and disability of patients with advanced schistosomiasis japonica. PloS
Neglected Tropical Diseases 5: e966.
16. Ziegelbauer K, Steinmann P, Zhou H, Du Z-W, Jiang J-Y, et al. (2010) Self-
rated quality of life and school performance in relation to helminth infections:
case study from Yunnan, People’s Republic of China. Parasites and Vectors 3:
61.
17. WHOQOL Group (1995) The World Health Organization Quality of Life
Assessment (WHOQOL). Position paper from the Word Health Organization.
Social Science and Medicine 41: 1403–1409.
18. WHO (1946) WHO definition of Health. Preamble to the Constitution of the
World Health Organization. In: International Health Conference NY, 19–22
June, 1946, editor: Official Records of the World Health Organization.
19. Eiser C, Morse R (2001) Quality-of-life measures in chronic diseases of
childhood. Health Technology Assessment 5: 1–157.
20. Kamel MI, Ghafar YA, Foda N, Khashab S (2001) Impact of type and stage of
schistosomiasis on quality of life and productivity of infected workers. J Egypt
Soc Parasitol 31: 153–167.
21. Budke CM, Jiamin Q, Zinsstag J, Qian W, Torgerson PR (2004) Use of disability
adjusted life years in the estimation of the disease burden of echinococcosis for a
high endemic region of the Tibetan plateau. American Journal of Tropical
Medicine and Hygiene 71: 56–64.
22. Leshem E, Maor Y, Meltzer E, Assous M, Schwartz E (2008) Acute
schistosomiasis outbreak: Clinical features and economic impact. Clinical
Infectious Diseases 47: 1499–1506.
23. Verani JR, Abudho B, Montgomery SP, Mwinzi PN, Shane HL, et al. (2011)
Schistosomiasis among young children in Usoma, Kenya. American Journal of
Tropical Medicine and Hygiene 84: 787–791.
24. Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of
life. Annals of Internal Medicine 118: 622–629.
25. Terwee CB, Bot SD, de Boer MR, van der Windt DAWM, Knol DL, et al.
(2007) Quality criteria were proposed for measurement properties of health
status questionnaires. Journal of Clinical Epidemiology 60: 34–42.
26. Varni JW, Seid M, Rode CA (1999) The PedsQLTM: Measurement model for
the Pediatric Quality of Life Inventory. Medical Care 37: 126–139.
27. Varni JW, Seid M, Kurtin PS (2001) PedsQLTM 4.0: Reliability and validity of
the Pediatric Quality of Life InventoryTM version 4.0 generic core scales in
healthy and patient populations. Medical Care 39: 800–812.
28. Varni JW, Burwinkle TM, Seid M, Skarr D (2003) The PedsQLTM 4.0 as a
pediatric population health measure: feasibility, reliability, and validity.
Ambulatory Pediatrics 3: 329–341.
29. Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, et al. (2003)
The PedsQLTM in Type 1 and Type 2 diabetes: Reliability and validity of the
Pediatric Quality of Life InventoryTM generic core scales and Type 1 diabetes
module. Diabetes Care 26: 631–637.
30. Goldstein SL, Graham N, Warady BA, Seikaly M, McDonald R, et al. (2008)
Measuring health-related quality of life in children with ESRD: Performance of
the Generic and ESRD-Specific Instrument of the Pediatric Quality of Life
InventoryTM (PedsQLTM). American Journal of Kidney Diseases 51: 285–297.
31. Weissberg-Benchell J, Zielinski TE, Rodgers S, Greenley RN, Askenazi D, et al.
(2010) Pediatric health-related quality of life: Feasibility, reliability and validity of
the PedsQLTM Transplant Module. American Journal of Transplantation 10:
1686–1694.
32. Limbers CA, Ripperger-Suhler J, Boutton K, Ransom D, Varni JW (2011) A
comparative analysis of health-related quality of life and family impact between
Quality of Life with Urogenital Schistosomiasis
PLOS Neglected Tropical Diseases | www.plosntds.org 12 March 2013 | Volume 7 | Issue 3 | e2106
children with ADHD treated in a general pediatric clinic and a psychiatric clinic
utilizing the PedsQLTM. Journal of Attention Disorders 15: 392–402.
33. Davis SE, Hynan LS, Limbers CA, Andersen CM, Greene MC, et al. (2010)
The PedsQLTM in pediatric patients with Duchenne Muscular Dystrophy:
Feasibility, reliability, and validity of the Pediatric Quality of Life InventoryTM
Neuromuscular Module and Generic Core Scales. Journal of Clinical
Neuromuscular Disease 11: 97–109.
34. Seid M, Limbers CA, Driscoll KA, Opipari-Arrigan LA, Gelhard LR, et al.
(2010) Reliability, validity, and responsiveness of the Pediatric Quality of Life
InventoryTM (PedsQLTM) Generic Core Scales and Asthma Symptoms Scale in
vulnerable children with asthma. Journal of Asthma 47: 170–177.
35. King CH (2006) Long-term outcomes of school-based treatment for control of
urinary schistosomiasis: a review of experience in Coast Province, Kenya.
Memo´rias do Instituto Oswaldo Cruz 101: 299–306.
36. Mutuku FM, King CH, Bustinduy AL, Mungai P, Muchiri EM, et al. (2011)
Impact of drought on the spatial pattern of transmission of Schistosoma
haematobium in Coastal Kenya. American Journal of Tropical Medicine and
Hygiene 85: 1065–1070.
37. Mutuku FM, King CH, Mungai P, Mbogo CM, Mwangangi JM, et al. (2011)
Impact of insecticide treated bednets on malaria transmission indices on the
south coast of Kenya. Malaria Journal 10: 356.
38. Peters PA, Warren KS, Mahmoud AA (1976) Rapid, accurate quantification of
schistosome eggs via nuclepore filters. J Parasitol 62: 154–155.
39. Katz N, Chaves A, Pellegrino J (1972) A simple device for quantitative stool
thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo
14: 397–400.
40. WHO/CDC (2007) Assessing the iron status of populations: report of a Joint
World Health Organization/Centers for Disease Control and Prevention.
Technical consultation on the assessment of iron status at the population level.
2nd ed. Geneva, Switzerland, 6–8 April 2004. -.
41. WHO (2009) WHO Multicentre Growth Reference Study Group. WHO Child
Growth Standards:Growth velocity based on weight, length and head
circumference: Methods and development Geneva: World Health Organization.
42. de Onis M (2009) Growth curves for school age children and adolescents. Indian
Pediatrics 46: 463–465.
43. WHO/UNICEF (2009) WHO child growth standards and the identification of
severe acute malnutrition in infants and children. Geneva, Switzerland. 1–12 p.
44. Fairclough DL (2002) Design and Analysis of Quality of Life Studies in Clinical
Trials: Interdisciplinary Statistics. New York: Chapman & Hall/CRC.
45. Varni JW, Limbers CA, Burwinkle TM (2007) How young can children reliably
and validly self-report their health-related quality of life?: An analysis of 8,591
children across age subgroups with the PedsQLTM 4.0 Generic Core Scales.
Health and Quality of Life Outcomes 5: 1.
46. Gwatkin DR, Rustein S, Johnson K, Pande R, Wagstaff A (2000) Socio-
economic Differences in Health, Nutrition, and Population in Kenya.
Washington, DC: World Bank. 28 p.
47. McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical
practice: Are available health status surveys adequate? Quality of Life Research
4: 293–307.
48. Cronbach LJ (1951) Coefficient alpha and the internal structure of tests.
Psychometrika 16: 297–334.
49. Nunnally JC, Bernstein IR (1994) Psychometric Theory. 3rd edition; New York:
McGraw-Hill.
50. Cohen J (1988) Statisical Power Analysis for the Behavioral Sciences. 2nd edition.
Hillsdale: Erlbaum.
51. Kazis LE, Anderson JJ, Meenan RF (1989) Effect sizes for interpreting changes
in health status. Medical Care 27: 178–189.
52. Fowler FJ (1995) Improving Survey Questions: Design and Evaluation:
Thousand Oaks, CA: Sage.
53. McGraw KO, Wong SP (1996) Forming inferences about some intraclass
correlation coefficients. Psychological Methods 1: 30–46.
54. Bartko JJ (1966) The intraclass correlation coefficient as a measure of reliability.
Psychological Reports 19: 3–11.
55. WHO (2002) Prevention and control of schistosomiasis and soil-transmitted
helminthiasis: report of a WHO expert committee. WHO Tech Rep Ser 912. 1–
57.
56. Friedman JF, Kanzaria HK, Acosta LP, Langdon GC, Manalo DL, et al. (2005)
Relationship between Schistosoma japonicum and nutritional status among children
and young adults in Leyte, the Philippines. American Journal of Tropical
Medicine and Hygiene 72: 527–533.
57. King CH (2010) Parasites and poverty: the case of schistosomiasis. Acta Tropica
113: 95–104.
58. Zhou H, Ohtsuka R, He Y, Yuan L, Yamauchi T, et al. (2005) Impact of
parasitic infections and dietary intake on child growth in the schistosomiasis-
endemic Dongting region, China. American Journal of Tropical Medicine and
Hygiene 72: 534–539.
59. Bethony J, Williams JT, Kloos H, Blangero J, Alves-Fraga L, et al. (2001)
Exposure to Schistosoma mansoni infection in a rural area in Brazil. II: Household
risk factors. Tropical Medicine and International Health 6: 136–145.
60. Raso G, Utzinger J, Silue´ KD, Ouattara M, Yapi A, et al. (2005) Disparities in
parasitic infections, perceived ill health and access to health care among poorer
and less poor schoolchildren of rural Coˆte d’Ivoire. Tropical Medicine and
International Health 10: 42–57.
61. Savioli L, Hatz C, Dixon H, Kisumku UM, Mott KE (1990) Control of
morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and
hematuria as indicators of infection. American Journal of Tropical Medicine and
Hygiene 43: 289–295.
62. Kvalsvig JD (1981) The effects of schistosomiasis on spontaneous play activity in
black schoolchildren in the endemic areas. An ethological study. S Afr Med J 60:
61–64.
63. Chan KS, Mangione-Smith R, Burwinkle TM, Rosen M, Varni JW (2005) The
PedsQLTM: reliability and validity of the short-form generic core scales and
asthma module. Medical Care 43: 256–265.
64. Chen X, Origasa H, Ichida F, Kamibeppu K, Varni JW (2007) Reliability and
validity of the Pediatric Quality of Life InventoryTM (PedsQLTM) Short Form 15
generic core scales in Japan. Quality of Life Research 17: 1239–1249.
65. Raat H, Landgraf JM, Oostenbrink R, Moll HA, Essink-Bot M-L (2007)
Reliability and validity of the Infant and Toddler Quality of Life Questionnaire
(ITQOL) in a general population and respiratory disease sample. Quality of Life
Research 16: 445–460.
Quality of Life with Urogenital Schistosomiasis
PLOS Neglected Tropical Diseases | www.plosntds.org 13 March 2013 | Volume 7 | Issue 3 | e2106
